Korea United Pharm Inc. (KRX: 033270)

Korea United Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Sep 30, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Cash & Equivalents	20,206	31,118	26,438	16,819	18,000	7,447
Short-Term Investments	17,994	11,719	615.09	9,356	384.56	486.47
Cash & Short-Term Investments	38,201	42,837	27,053	26,175	18,384	7,933
Cash Growth	18.00%	58.35%	3.35%	42.37%	131.74%	-15.74%
Accounts Receivable	43,015	39,294	36,221	35,025	41,215	43,769
Other Receivables	1,784	898.78	351.25	744.34	425.25	573.5
Receivables	45,587	41,129	38,431	36,746	46,417	46,653
Inventory	26,062	27,209	27,070	30,035	22,729	17,301
Prepaid Expenses	228.77	143.6	97.18	179.42	318.17	162.23
Other Current Assets	118.98	108.69	175.07	48.05	101.23	102.02
Total Current Assets	110,197	111,427	92,825	93,184	87,950	72,152
Property, Plant & Equipment	74,121	67,003	65,494	59,686	53,645	46,521
Long-Term Investments	11,902	12,071	8,709	8,434	8,494	6,117
Other Intangible Assets	4,405	3,572	2,349	2,309	1,673	1,631
Long-Term Accounts Receivable	-	-	-	0	-	-
Other Long-Term Assets	17,621	17,832	17,773	17,757	16,767	15,994
Total Assets	223,904	217,101	193,539	187,577	170,086	144,539
Accounts Payable	6,585	4,995	6,693	5,274	4,965	4,000
Accrued Expenses	10,005	10,572	9,628	8,893	9,573	10,263
Short-Term Debt	3,050	3,282	1,724	6,738	15,695	17,334
Current Portion of Long-Term Debt	3,462	1,708	3,783	5,803	2,077	1,420
Current Portion of Leases	-	-	-	-	441.8	-
Current Income Taxes Payable	2,130	3,901	709.83	2,071	1,620	755.2
Current Unearned Revenue	-	-	-	-	2.48	-
Other Current Liabilities	4,171	3,967	4,122	5,805	4,069	3,477
Total Current Liabilities	29,403	28,425	26,659	34,584	38,443	37,249
Long-Term Debt	17,130	19,779	18,307	10,690	9,144	6,201
Long-Term Unearned Revenue	764.18	723.81	287.79	261.83	221.78	595.42
Long-Term Deferred Tax Liabilities	3,231	3,573	4,223	4,080	2,962	2,962
Other Long-Term Liabilities	2,696	2,766	2,625	4,485	6,272	3,407
Total Liabilities	53,225	55,266	52,102	54,100	57,043	50,415
Common Stock	8,104	8,104	7,742	7,742	7,742	7,513
Additional Paid-In Capital	17,714	17,719	14,143	14,151	13,252	11,131
Retained Earnings	148,628	136,528	118,913	108,558	93,807	75,062
Treasury Stock	-6,000	-2,731	-2,713	-	-4,515	-2,536
Comprensive Income & Other	2,226	2,208	3,345	3,017	2,746	2,944
Total Common Equity	170,672	161,828	141,430	133,469	113,032	94,114
Minority Interest	7.12	6.6	7.27	8.43	11.21	10.69
Shareholders' Equity	170,679	161,835	141,437	133,477	113,043	94,124
Total Liabilities & Equity	223,904	217,101	193,539	187,577	170,086	144,539
Total Debt	23,642	24,768	23,814	23,231	27,358	24,955
Net Cash (Debt)	14,559	18,069	3,239	2,943	-8,973	-17,021
Net Cash Growth	230.84%	457.86%	10.04%	-	-	-
Net Cash Per Share	916.88	1140.84	203.16	194.26	-615.57	-1131.06
Filing Date Shares Outstanding	15.71	15.91	15.18	16.11	15.09	14.93
Total Common Shares Outstanding	15.71	15.91	15.18	16.11	15.09	14.93
Working Capital	80,795	83,002	66,166	58,600	49,507	34,903
Book Value Per Share	10866.83	10174.19	9313.85	8284.58	7491.25	6305.22
Tangible Book Value	166,267	158,256	139,081	131,160	111,358	92,483
Tangible Book Value Per Share	10586.38	9949.62	9159.14	8141.28	7380.36	6195.98
Land	25,454	21,005	20,225	19,903	19,780	18,890
Buildings	42,250	41,430	39,618	32,706	27,716	25,446
Machinery	47,212	43,600	47,255	37,989	34,699	33,170
Construction In Progress	4,676	1,793	2,175	7,144	6,657	2,689

Source: S&P Capital IQ. Standard template. Financial Sources.